Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome

NCT04920149 is registered in ClinicalTrials.gov with Ann-Sofie Backman as lead sponsor.

NCT NCT04920149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04920149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Lead sponsor
Ann-Sofie Backman
Phase
Phase 2
Overall status
Recruiting
Start date
March 21, 2022
Completion date
September 30, 2045
Enrollment
150 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, colon neoplasm, lynch syndrome